RxDoctor Payments Data

Jason So, DO

Family Medicine · Lake Geneva, WINPI 1508078643

Payments from drug & device makers

$615in general payments, 2019–2025

Across 38 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$187
  • Pfizer$136
  • Alkermes, Inc.$66
  • GSK$49
  • Lilly USA, LLC$45
  • Scilex Pharmaceuticals Inc.$42
  • plus $91 from 4 others

What the payments were for

  • Food & beverage$60598%
  • Education$112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$615 in reported general payments places this provider in the 80th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$242,881
Medicare patients
398
Services billed
3,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban147$125,535
TrulicityDulaglutide72$110,590
JardianceEmpagliflozin85$96,931
FarxigaDapagliflozin Propanediol40$40,713
JanuviaSitagliptin Phosphate33$31,334
MounjaroTirzepatide18$24,778
Spiriva HandihalerTiotropium Bromide25$23,334
Tresiba Flextouch U-200Insulin Degludec18$17,263
OzempicSemaglutide16$16,006
InvokanaCanagliflozin17$15,320
Tresiba Flextouch U-100Insulin Degludec19$15,128
Breo ElliptaFluticasone/Vilanterol27$13,891
Lantus SolostarInsulin Glargine,hum.Rec.Anlog104$13,622
EntrestoSacubitril/Valsartan14$13,405
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$11,509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$45$135,36890 claims
PfizerEliquis$136$125,535147 claims
AstraZenecaFarxiga, Symbicort$187$45,48158 claims
MerckJanuvia$37$31,33433 claims
GSKBreo Ellipta, Arnuity Ellipta$49$20,82751 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Lake Geneva

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →